搜索筛选:
搜索耗时2.9917秒,为你在为你在102,285,761篇论文里面共找到 6 篇相符的论文内容
发布年度:
Polymorphisms in methylenetetrahydrofolate reductase gene: Their impact on liver steatosis and fibro
[期刊论文] 作者：Engin Altintas,Zuhal Mert Alti,
来源：肠胃病学期刊(英文) 年份：2014
Aim & Background: The mechanism of steatosis in Hepatitis C virus infection is multifactorial;therefore, it is complex and unclear. The aim of this study was to...
[期刊论文] 作者：Engin Altintas,Serap Yalin,Orh,
来源：再生医学期刊(英文) 年份：2019
Aim & Background: It was proposed that the differences in erythrocyte membrane protein contents—especially band 4—take a role in the serious anemia related to...
Maastricht Ⅱ treatment scheme and efficacy of different proton pump inhibitors in eradicating Helico
[期刊论文] 作者：Engin Altintas,Orhan Sezgin,Oguz Ulu,Ozlem Aydin,Handan Camdeviren,
来源：世界胃肠病学杂志（英文版） 年份：2004
AIM: The Maastricht Ⅱ criteria suggest the use of amoxicillin and clarithromycin in addition to a proton pump inhibitor over 7-10 d as a first line therapy in...
Effects of terlipressin on systolic pulmonary artery pressure of patients with liver cirrhosis: An e
[期刊论文] 作者：Engin Altintas,Necdet Akkus,Ramazan Gen,M.Rami Helvaci,Orhan Sezgin,Dilek Oguz,,
来源：World Journal of Gastroenterology 年份：2004
AIM:Portopulmonary hypertension is a serious complicationof chronic liver disease.Our aim was to search into theeffect of terlipressin on systolic pulmonary ar...
Effects of terlipressin on systolic pulmonary artery pressure of patients with liver cirrhosis:An ec
[期刊论文] 作者：Engin Altintas,Necdet Akkus,Ramazan Gen,M. Rami Helvaci,Orhan Sezgin,Dilek Oguz,
来源：世界胃肠病学杂志（英文版） 年份：2004
AIM: Portopulmonary hypertension is a serious complication of chronic liver disease. Our aim was to search into the effect of terlipressin on systolic pulmonary...
Effect of interferon and ribavirin combined with amantadine in interferon and ribavirin non-responde
[期刊论文] 作者：Dilek Oguz,Bahattin Cicek,Levent Filik,Bulent Odemis,Mesut Kilic,Engin Altintas,Neslihan Zengin,Emin,
来源：World Journal of Gastroenterology 年份：2005
AIM: To evaluate the efficacy of amantadine plus interferon-alpha and ribavirin in non-responder patients with chronic hepatitis C. METHODS: Twenty-six non-resp...
相关搜索：
